{"id":"W4366064463","doi":"10.1002/ana.64","title":"European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis","year":2001,"lang":"en","type":"article","venue":"Annals of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":608,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Glatiramer acetate; Medicine; Placebo; Multiple sclerosis; Magnetic resonance imaging; Randomized controlled trial; Confidence interval; Clinical trial; Lesion; Nuclear medicine; Internal medicine; Surgery; Radiology; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04746573707919739,"score_gpt":0.287752972457593,"score_spread":0.2402872353783956,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}